 Clinical Dilemmas in Inflammatory Bowel Disease
ISBN: 978-1-4051-3377-7
Paperback
264 pages
July 2006, Wiley-Blackwell
US $64.95
 Add to Cart
This price is valid for United States. Change location to view local pricing and availability. Other Available Formats: Adobe E-Book
|
An online version of this product is available through our subscription-based content service. Visit Wiley InterScience now |
Part 1 Investigating IBD in the 21st Century.
1 Capsule endoscopy: do we need it?.
2 Pathology reports - pitfalls for the unwary.
3 Non-invasive diagnosis and assessment.
4 What is the best way to image perianal Crohn's disease?.
5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome.
6 Abnormal liver tests - what should we do about them?.
Part 2 Medical Treatment: Making the Most of What We've Got.
5-ASA drugs.
7 Is monitoring necessary?.
8 Do they have a role in Crohn's disease?.
Steroids.
9 Steroids in Crohn's: are they obsolete?.
Antibiotics for Crohn's disease.
10 Antibiotics: which, when and for how long?.
11 Mycobacterium avium paratuberculosis in Crohn's disease: player or spectator?.
Immunomodulators.
12 TPMT testing: is it essential? .
13 6-Mercaptopurine or azathioprine?.
14 Thiopurines: how long should we use them for?.
15 Making the most of methotrexate.
16 Cyclosporine: balancing risk and benefit.
Infliximab.
17 Contraindications - absolute or relative?.
18 How can we prevent tuberculosis?.
19 Dealing with infusion reactions.
20 Use in ulcerative colitis.
21 Infliximab and surgery: health or hazard?.
Nutritional therapy for Crohn's disease.
22 Nutritional therapy for Crohn's disease: is it for adults?.
Part 3 Medical Treatment: What's Round the Corner?.
23 Trials and tribulations - interpreting clinical trials in IBD.
24 Genetics - clinical and therapeutic applications.
25 Probiotics - separating science from snakeoil.
26 Worms.
27 Smoking and nicotine - poison for Crohn's, potion for colitis?.
28 Heparin.
29 Leukocytapheresis: filtering out the facts.
30 Appendectomy for ulcerative colitis - a therapeutic option?.
31 Biologic treatments in IBD.
32 Stem cell transplantation for IBD.
33 Complementary and alternative therapy - the way forward or a step back?.
Part 4 Common Clinical Challenges: Beyond the Text Book.
34 Functional problems.
35 Psychological stress: something to worry about?.
36 Drugs to avoid.
37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?.
38 Iron replacement - is it safe and effective?.
39 Hepatitis B and C viruses - how do they affect management of IBD?.
40 Pregnancy: what drugs can we use?.
41 How to prevent growth failure in children.
42 Predicting outcomes in severe UC.
43 Refractory proctitis.
44 CMV co-infection - does it matter?.
45 Treatment of oral Crohn's disease.
46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease.
47 Short bowel.
48 Management of internal fistulae.
49 What is indeterminate colitis? .
50 Pouches for indeterminate colitis?.
51 Colitis-associated cancer: what's the risk to your patients? .
52 What to do with dysplasia, DALMs, and adenomas.
Part 5 Managing IBD Outside the Gut.
53 Pyoderma gangrenosum.
54 Arthritides - helping the joints without harming the gut.
55 Prevention and treatment of osteoporosis.
56 Sclerosing cholangitis - what to do?.
57 Thromboembolic disease: an under-recognized complication?.
58 Pulmonary manifestations: rare but real.
Part 6 Are You Sure it's IBD?.
59 Intestinal infections: mimics and precipitants of relapse.
60 Microscopic colitis.
61 Diverticular colitis.
Part 7 The IBD Service: Time for a Rethink?.
62 Outpatient services - do doctors still have a role?.
63 Shared care: tactical team selection.
64 Databases - are they worth the bother?.
Index
1 Capsule endoscopy: do we need it?.
2 Pathology reports - pitfalls for the unwary.
3 Non-invasive diagnosis and assessment.
4 What is the best way to image perianal Crohn's disease?.
5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome.
6 Abnormal liver tests - what should we do about them?.
Part 2 Medical Treatment: Making the Most of What We've Got.
5-ASA drugs.
7 Is monitoring necessary?.
8 Do they have a role in Crohn's disease?.
Steroids.
9 Steroids in Crohn's: are they obsolete?.
Antibiotics for Crohn's disease.
10 Antibiotics: which, when and for how long?.
11 Mycobacterium avium paratuberculosis in Crohn's disease: player or spectator?.
Immunomodulators.
12 TPMT testing: is it essential? .
13 6-Mercaptopurine or azathioprine?.
14 Thiopurines: how long should we use them for?.
15 Making the most of methotrexate.
16 Cyclosporine: balancing risk and benefit.
Infliximab.
17 Contraindications - absolute or relative?.
18 How can we prevent tuberculosis?.
19 Dealing with infusion reactions.
20 Use in ulcerative colitis.
21 Infliximab and surgery: health or hazard?.
Nutritional therapy for Crohn's disease.
22 Nutritional therapy for Crohn's disease: is it for adults?.
Part 3 Medical Treatment: What's Round the Corner?.
23 Trials and tribulations - interpreting clinical trials in IBD.
24 Genetics - clinical and therapeutic applications.
25 Probiotics - separating science from snakeoil.
26 Worms.
27 Smoking and nicotine - poison for Crohn's, potion for colitis?.
28 Heparin.
29 Leukocytapheresis: filtering out the facts.
30 Appendectomy for ulcerative colitis - a therapeutic option?.
31 Biologic treatments in IBD.
32 Stem cell transplantation for IBD.
33 Complementary and alternative therapy - the way forward or a step back?.
Part 4 Common Clinical Challenges: Beyond the Text Book.
34 Functional problems.
35 Psychological stress: something to worry about?.
36 Drugs to avoid.
37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?.
38 Iron replacement - is it safe and effective?.
39 Hepatitis B and C viruses - how do they affect management of IBD?.
40 Pregnancy: what drugs can we use?.
41 How to prevent growth failure in children.
42 Predicting outcomes in severe UC.
43 Refractory proctitis.
44 CMV co-infection - does it matter?.
45 Treatment of oral Crohn's disease.
46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease.
47 Short bowel.
48 Management of internal fistulae.
49 What is indeterminate colitis? .
50 Pouches for indeterminate colitis?.
51 Colitis-associated cancer: what's the risk to your patients? .
52 What to do with dysplasia, DALMs, and adenomas.
Part 5 Managing IBD Outside the Gut.
53 Pyoderma gangrenosum.
54 Arthritides - helping the joints without harming the gut.
55 Prevention and treatment of osteoporosis.
56 Sclerosing cholangitis - what to do?.
57 Thromboembolic disease: an under-recognized complication?.
58 Pulmonary manifestations: rare but real.
Part 6 Are You Sure it's IBD?.
59 Intestinal infections: mimics and precipitants of relapse.
60 Microscopic colitis.
61 Diverticular colitis.
Part 7 The IBD Service: Time for a Rethink?.
62 Outpatient services - do doctors still have a role?.
63 Shared care: tactical team selection.
64 Databases - are they worth the bother?.
Index
